West to Participate in Upcoming Investor Conferences

EXTON, Pa., Oct. 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences: 

• UBS Global Healthcare Conference: Fireside chat at 9:30 AM ET on Tuesday, November 11, 2025, in Palm Beach Gardens, FL.
• Jefferies Global Healthcare Conference: Fireside chat at 10:00 AM GMT on Tuesday, November 18, 2025, in London, UK.
• Stephens Annual Investment Conference: Fireside chat at 11:00 AM CT on Thursday, November 20, 2025, in Nashville, TN.
• Citi Global Healthcare Conference: Fireside chat at 2:30 PM ET on Tuesday, December 2, 2025, in Miami, FL.

The live webcast for each of these events can be accessed in the Investors section of the Company's website. A replay of each webcast will also be available on the Company's website for approximately 90 days after the respective event. 

About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.  

Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com. 

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. 

SOURCE West Pharmaceutical Services, Inc.